About
128.60EUR+2.20 +1.74%
Closed • Updated at 23:17 GMT+00:00Market Cap$64.95B
P/E Ratio22.08
Volume371.8K
Beta1.48
RSI70.98
Gross Margin58.53%
Merck Kgaa — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2026
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
May 7 2026
MilliporeSigma Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
Apr 30 2026
Merck KGaA, Darmstadt, Germany, Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
Apr 28 2026
Remepy Announces Collaboration with Merck KGaA, Darmstadt Germany to Advance Hybrid Drugs Across Therapeutic Areas
Apr 21 2026
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
Community Chat
Ask AI
Try asking
Translate